AriMed Advisors
VC Fund
Shanghai, China
AriMed Advisors is a VC fund in Shanghai focused on Biotechnology and Medical. AriMed Advisors is one of the leading financial advisory and strategy consulting firms to corporations within Chinese healthcare & life sciences and related industries. They provide an integrated advisory service in raising capital, growth strategy, M&A and divestiture transactions, and initial public offerings. The combination of industryleadership, deep sector expertise and long-term growth strategies drives business transformation. Their firm has a unique specialization in hospital management and development strategy.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries AriMed Advisors invests in
Stages AriMed Advisors invests in
Countries AriMed Advisors invests in
Investment Focus
Industry
- Biotechnology 2 (100%)
- Medical 1 (50%)
- Health Care 1 (50%)
Stage
- Seed 1 (50%)
- Series A 1 (50%)
Country
- China 1 (50%)
- United States 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ArrePath
|
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections. | $20M / Seed / Mar 03, 2022 | |
Ligatech Bioscience
|
Ligatech Bioscience is an intrusive consumables developer specializing in the development and manufacture of medical devices for the field of sports medicine, as well as the development and production of biomedical materials and products. A production line for artificial ligaments and artificial ligament fixation systems has been established. Andprovide users with relevant technical advice and technical services. | Series A / Nov 09, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does AriMed Advisors invest in?
AriMed Advisors invests primarily in Biotechnology, Medical and Health Care startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did AriMed Advisors last invest?
The most recent investment recorded for AriMed Advisors closed in Mar 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
